AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
about
Psychosocial interventions for cannabis abuse and/or dependence among persons with co-occurring cannabis use and psychotic disordersAlterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant SchizophreniaGone to Pot - A Review of the Association between Cannabis and PsychosisThe Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosisDifferent Paths to Core Pathology: The Equifinal Model of the Schizophrenia SyndromeAnimal models of gene-environment interaction in schizophrenia: A dimensional perspective.Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression.Neurodevelopment in schizophrenia: the role of the wnt pathways.Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human CognitionImpact of Cannabis Use on the Development of Psychotic DisordersFunctional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior.The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.Cannabinoids and Schizophrenia: Risks and Therapeutic PotentialGABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokersTraditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.The epigenome and postnatal environmental influences in psychotic disorders.New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.The link between schizophrenia and substance use disorder: A unifying hypothesis.Evidence That the Impact of Childhood Trauma on IQ Is Substantial in Controls, Moderate in Siblings, and Absent in Patients With Psychotic Disorder.Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome.Genotype-based prevention of psychosis onset and schizophrenia: a personalized approach in a target population.
P2860
Q24186871-5933616D-BD23-4AF4-A086-8DBE4587EF53Q26773403-EB1ABF5F-695C-48BB-A5FE-BCD30D011EB2Q26865311-52377900-8084-428F-B3F3-EEF0BACD66D9Q28545094-495AA9D5-A7CB-4E74-AF3C-0C9B1A6474FAQ30357827-FC5C54D8-2FCE-4062-9B2E-ADC680745651Q30367009-353BF056-1DC5-476C-B2B1-C4F2B93EABC8Q30437684-C2A8ECF5-F0AA-492C-825E-34F5F44D1A71Q30442237-8D1FCB21-44D0-4D32-8DFA-A967962AE025Q33700887-BDB86EDD-5608-4F65-B361-A20D44033890Q34668606-8CF4F39A-74F6-4E28-9536-1D5DBD4A0FE2Q34906834-96DC91F5-BFA8-40BB-8368-3755B527EE1DQ35382798-97D4283C-DDA9-4E18-9936-F43E8FE4DD03Q35950814-DA26A5D5-80D5-4B4E-9CE6-0D18C017C5FCQ36101350-63BA78A8-172D-4816-AB87-8E1667289C6BQ36157669-9E0AAC9F-7E4A-45E5-8CAA-6712194177FBQ36821827-E7C60D06-D7A9-442B-8D81-861FE6A8E75AQ36915433-74491668-0E0D-4CCE-8D3A-E3E02B332FE1Q37274656-E7D319A1-59BB-44BA-9393-408681CC57A8Q38189293-21ACADB9-5193-4F7F-8F51-9F131463FC91Q38729316-A3E90C44-6242-4910-A6C4-7EF9C2A0099AQ38729376-AC26528C-9D78-4790-9567-91711A4355B9Q38972574-1C520B9F-05B9-4D4B-B350-E579F05B057BQ40209149-195D95DE-1531-482A-89BF-E32E041547CAQ48635191-0DED82AD-827B-4738-B32D-4013FC06BD67Q52559088-328F132B-EF40-4110-A17A-82957708C4F6Q54295921-EC03C3D3-DBD1-447B-938A-87F37F3A6AF9
P2860
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@ast
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@en
type
label
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@ast
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@en
prefLabel
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@ast
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@en
P2093
P2860
P356
P1476
AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.
@en
P2093
Claudia Simons
Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Nico J M van Beveren
Ruud van Winkel
P2860
P2888
P304
P356
10.1038/NPP.2011.141
P407
P577
2011-07-20T00:00:00Z
P5875
P6179
1004977315